【レポートの概要(一部)】
1. Report Overview
1.1 Global Pharma Wholesale and Distribution Industry and Market Overview
1.2 Pharma Wholesale and Distribution Industry Structure
1.3 Benefits of This Report
1.4 How This Report Delivers
1.5 Main Questions This Report Answers
1.6 Who is This Report For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Some Related Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistic Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribute a Large Amount of Products to Generate High Profit
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generating Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clear Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market, 2015-2025
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2014, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution: World Market Forecast, 2015-2025
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2015-2025
3.3.1 Branded and Generic Drugs: Revenue Generation, 2014
3.3.2 Branded Drugs: Revenue Forecast, 2015-2025
3.3.3 Generic Drugs: Revenue Forecast, 2015-2025
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2015-2025
4.1 The Leading National Markets: The US Dominates in 2014
4.2 The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2015-2025
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 Difference Between the US and Europe
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2015-2025
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2014
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.4.5 France: Pharma Wholesale and Distribution Market, 2014
4.4.5.1 France: Social Security Finance Bill 2014
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2014
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2014
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.4.8 UK: Pharma Wholesale and Distribution Market, 2014
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.5 Japan: Pharma Wholesale and Distribution Market, 2014
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.6 China: Pharma Wholesale and Distribution Market, 2014
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2014
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.7 Brazil: Pharma Wholesale and Distribution Market, 2014
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2014
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.8 India: Pharma Wholesale and Distribution Market, 2014
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.9 Russia: Pharma Wholesale and Distribution Market, 2014
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2015-2025
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2015: Current and Future Performance
5.1 The Leading Pharma Wholesalers and Distribution Companies in 2014
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2015-2025
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2009-2014
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2015-2025
5.5 Cardinal Health: The World’s third Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2010-2014
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2015-2025
5.6 AmerisourceBergen: Second Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2010-2014
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast, 2015-2025
5.7 Walgreens Boots Alliance: The Largest Drugstore Chain in the US and Global Wholesale and Distribution Network
5.7.1 Walgreens Boots Alliance: Historical Performance, 2010-2014
5.7.2 Acquisitions and Future Strategies of Walgreens Boots Alliance
5.7.3 Walgreens Boots Alliance: Revenue Forecast, 2015-2025
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2010-2014
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2015-2025
5.9 The PHOENIX Group: Biggest European Wholesaler
5.9.1 The PHOENIX Group: Historical Performance, 2010-2014
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisitions
5.9.3 The PHOENIX Group: Revenue Forecast, 2015-2025
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2010-2014
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2015-2025
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2010-2014
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2015-2025
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO., LTD: Historical Performance, 2010-2014
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2015-2025
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2010-2014
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2015-2025
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 The Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2015
6.1.1 The Insatiable Demand for Drugs: A Recession-Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2 The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2015-2025
6.2.1 The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country to Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4.0 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2015-2025 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.3.2.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interview
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd. (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market in the UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK?
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More Than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
8. Conclusions from the Research and Analysis
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesalers’ Costs
【レポート販売概要】
■ タイトル:医薬品卸売/流通の世界市場動向及び予測■ 英文:World Pharma Wholesale and Distribution Industry and Market: Trends, Developments and Commercial Predictions 2015-2025
■ 発行日:2015年10月
■ 調査会社:visiongain
■ 商品コード:VGAIN5102607
■ 調査対象地域:グローバル
- 医療用使い捨て器具の世界市場分析:製品別(創傷管理、薬物送達、診断・研究、透析、失禁、呼吸用品、滅菌、不織布)、材料別(プラスチック樹脂、不織布、ゴム、紙・板紙、金属、ガラス)、エンドユーザー別(病院、在宅医療、外来/プライマリケア施設)、セグメント予測The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure. In addition, propelling factors of this sector …
- 世界の軍事用電気光学・赤外線市場(2014-2024):動向、開発、課題Synopsis This report offers readers insights into technological developments in the Military Electro Optical Infrared (EO/IR) market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global …
- アンチエイジングサービスの世界市場:種類別(ケミカルピール、BOTOX、マイクロダーマブレーション、豊胸術、脂肪吸引術)、セグメント予測The global anti-aging services market size is likely to reach USD 35.43 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.3% during the forecast period. Growing aging population along with increasing life expectancy has created a high demand for anti-aging solutions. According to 2017 data revision of the World Population Prospects, the proportion …
- Nonalcoholic Steatohepatitis (NASH):市場分析及び予測(~2017)OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 Summary GlobalData has released its new report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017”. The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfi …
- 出退勤システム管理の世界市場:近接型カード、生体認証About Attendance Systems Management Managing attendance systems is an important aspect of supervision in nearly every organization. The solution helps track employees and their presence within the organization. By monitoring attendance, organizations can understand the behavior of employees, such as their arrival and departure times, vacation and sick days, and leaves of absence. Attendance system …
- 非結晶性ポリエチレンテレフタラートの世界市場予測(~2022年)“The amorphous polyethylene terephthalate (APET) market is estimated to be USD 28.86 billion in 2017 and is projected to reach USD 40.85 billion by 2022, at a CAGR of 7.2% during the forecast period from 2017 to 2022.” The amorphous polyethylene terephthalate (APET) market is estimated to be USD 28.86 billion in 2017 and is projected to reach USD 40.85 billion by 2022, at a CAGR of 7.2% during the …
- クラウド型マネージドサービスの世界市場2016-2020About Cloud-based Managed Services Cloud-based managed services consist of a wide range of services that help organizations to monitor, regulate, and improve the IT infrastructure of an organization. These services offer the advantages of cost containment and reduced inventory. These are required by organizations to develop an economical cost structure and minimize expenditure. Technavio’s analyst …
- Adenovirus Diagnostic:医療検査市場2014The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- CNC(コンピュータ数値制御)ソリューションの世界市場About CNC solutions CNC solutions are effective and efficient motion control systems that provide speedy and accurate execution of machining processes. These systems are deployed in manufacturing industries to create high-quality products. They are equipped with high-speed microprocessors to deliver high-precision machining processes with integrated safety functions for a foolproof and safe workin …
- 消火泡の世界市場予測・分析2020-2024Global Firefighting Foam Market: About this market Technavio’s firefighting foam market analysis considers sales from aqueous film-forming foam, alcohol-resistant aqueous film-forming foam, protein foam, synthetic detergent foam, and other forms. Our study also finds the sales of firefighting foam in APAC, Europe, MEA, North America, and South America. In 2019, the aqueous film-forming foam segmen …
- 医療分野における放射線診療用検知装置の世界市場Medical/healthcare is an established end-market for radiation detection equipment in many applications, and continues to drive improvements in and demand for radiology diagnostic systems. Radiography is one of the most important aspects of non-destructive testing (NDT), and is used in a wide variety of medical applications. The market for detectors has benefited from advancements in the science of …
- 世界のパワートレインコントロールモジュール(PCM)市場2015The Global Powertrain Control Module (PCM) Industry Report 2015 is a professional and in-depth study on the current state of the Powertrain Control Module (PCM) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Powertrain Control Module (PCM) market analysis is provided for the international markets …
- 自動車トランスミッションの世界市場予測(~2021):種類別(オートマチック、マニュアル、AMT、DCT、CVT)、車種別(乗用車、LCV、HCV、電気自動車(EV))、前進ギア数別、燃料別、地域別The automotive transmission market is projected to grow at a CAGR of 5.89% from 2016 to 2021, to reach a market size of USD 196.20 Billion. The major drivers of this market are the enhanced driving experience in terms of smooth gear shifting and improved acceleration, has contributed to a rise in vehicle production across developing nations like China, India and Brazil. The passenger car segment a …
- ヘキサンの世界市場分析:グレード別(重合、抽出)、用途別(食用油抽出、工業用溶剤、接着剤配合、皮革処理)、動向分析The global hexane market is expected to reach USD 2.36 billion by 2024, according to a new report by Grand View Research, Inc. The growth of oil extraction industry is expected to remain a key factor driving the global hexane market over the forecast period. Growing use of hexane across key end-use industries such as rubber and petrochemical is anticipated to boost the global market over the next …
- データセンター用発電機の世界市場2016-2020About the Generator Market for Data Centers Generators convert mechanical energy into electric energy. The source of mechanical energy can vary from internal combustion engine, hand crank, and compressed air, to reciprocating steam engine. Internal combustion engines use diesel, gasoline, propane gas, and natural gas to produce mechanical energy; this energy is converted into electric energy with …